Perrigo has filed an Abbreviated New Drug Application (ANDA) for clobetasol propionate topical spray, 0.05%, a generic form of Clobex Spray. Clobex (clobetasol propionate) spray is indicated for
Lentigen has received a National Institutes of Health (NIH) small business innovation research (SBIR) grant for a program on ‘A Novel Method of Generating Hepatitis C virus (HCV)
NanoMedex Pharmaceuticals (NanoMedex) was notified that it will be awarded a $2.23m Small Business Innovation Research (SBIR) Phase II Continuing Renewal grant from the National Institutes of Health
Sangart has initiated dose-finding study designed to evaluate the safety and efficacy of MP4OX treatment, plus standard of care, in severely injured trauma patients with lactic acidosis due
OvumOptics has introduced Ovu-Trac Ovulation Predictor Kit, which helps women increase their chances of conception, naturally, without medical intervention. The company said that Ovu-Trac kit uses saliva sampling
BioSystem Development has released the AssayMAP MAb Titer Assay for measuring antibody product concentrations (or titers) in bioprocess samples. Antibody titer assays are a critical bottleneck in biotherapeutic
NanoPacific (NPH) has acquired an exclusive license from University of California at Los Angeles (UCLA) for a suite of supramolecular nanoparticle technologies. Under the terms of the agreement
Ranbaxy and Nippon Chemiphar (NC) have announced the dissolution of their joint venture ‘Nihon Pharmaceutical Industry Co Ltd’ (NPI), in Japan. This follows an agreement between the two
Alexion has presented new data, which demonstrates the severe clinical burden of paroxysmal nocturnal hemoglobinuria (PNH) and the clinical benefits of Soliris (eculizumab) in 44 patients with no
Trubion Pharmaceuticals and Facet Biotech have presented the positive data from a phase 1 study of TRU-016 in patients with relapsed and refractory chronic lymphocytic leukemia (CLL) at
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.